Family-based program to reduce risk factors for schizophrenia spectrum disorders in youth with family history
Official title: Developing Biomarker-Supported SSD Prevention
Run by The University of Texas Health Science Center, Houston · NCT07743645 · Data updated 2026-11-12
This study tests a brief family-based psychosocial program to see if it lowers persistent psychotic-like experiences in kids and young adults with a family history of SSD and different brain risk patterns.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 9 Years to 26 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | April 1, 2031 |
| Study ends | April 1, 2031 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07743645 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are youths and young adults (9 to under 26) with a family history of SSD, at least two risk factors targeted by the intervention, and stable mental health on medication if applicable.
✕Probably not a fit
Individuals without a family history of SSD or without multiple targeted risk factors may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a brief family-centered psychosocial intervention against no specified control to address modifiable risk factors for schizophrenia spectrum disorders. Participants are children and young adults aged 9 to under 26 with a family history of SSD and two or more targeted risk factors, and who are psychiatrically stable. The trial focuses on those with both high and low baseline SSD-like brain patterns to see if the intervention reduces distressing psychotic-like experiences. Recruitment is centered at The University of Texas Health Science Center, Houston, with NIH collaboration. Exclusion criteria include prior or current psychotic disorders or CHR-p, and recent changes in antipsychotic medications.
Why it matters
Potential benefit: If successful, participants may experience fewer distressing psychotic-like experiences and reduced risk factors associated with SSD.
How similar studies have gone: Past work suggests psychosocial interventions can influence risk-related factors in high-risk populations, though this specific family-based approach for SSD prevention is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Family history of SSD (defined as first-degree (e.g., a parent or a sibling), second-degree (e.g., an uncle or a grandparent), or other combinations of biological relatives in the family have or likely have a diagnosis of SSD or other closely related severe mental illnesses equivalent to at least 25% of genetic sharing) per medical record review and/or parent/legal guardian/self report and confirmed by a structured interview; 2. screening positive for two or more risk factors targeted by the intervention; 3. aged ≥ 9 and \<26 years of birthday; 4. Participants and parent(s)/legal guardian(s)/other family member(s) agree to participate; 5. psychiatrically stable and have no major changes in antidepressant, stimulant, or antipsychotic medication in the past 4 weeks. Exclusion Criteria: 1. Current or past history of psychotic disorders or clinical high risk for psychosis (CHR-p) per study interview; 2. Current or past antipsychotic medication use to specifically treat a psychotic disorder; 3. major medical and neurological conditions; 4. moderate to severe intellectual disabilities or mild intellectual disabilities but expected to have difficulty completing the study assessments; 5. current drug or alcohol use that impacts functioning and study engagement; 6. Not able to give assent, permission, or consent; 7. Not able to undergo MRI.
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Yizhou Ma, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Yizhou Ma, PhD
- Email: Yizhou.Ma@uth.tmc.edu
- Phone: 713-486-2740
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal physical exercise program for people with psychosis on long-acting injectable antipsychotics
This program will try a supervised, structured exercise course to see if it improves physical fitness, mental well‑being, and metabolic health in adults with psychosis who are on long‑acting injectable antipsychotics.
-
Comparing intranasal oxytocin doses added to group psychotherapy for schizophrenia.
This study will try different doses of intranasal oxytocin given with mindfulness-based group psychotherapy to see if they reduce negative symptoms and improve social cognition in people with schizophrenia.
-
Circadian Variation of Anti-Factor Xa in Trauma Patients on LMWH
This study tests whether anti-Factor Xa levels show a daily rhythm in hospitalized trauma patients receiving LMWH for VTE prevention.
-
PrioritiesAI: A chat tool to help older adults with hernia decide what matters most for surgery
This study tests an AI-powered chat assistant to help people with hernia clearly express and communicate their health goals for elective surgery.
-
EUS-Guided RFA for Pancreatic Lesions: Safety and Outcomes
This study tests whether using endoscopic ultrasound-guided radiofrequency ablation is safe and helps patients with pancreatic lesions.
-
Skin-to-skin care with the Skincubator for preterm infants
This study tests whether using the Skincubator during skin-to-skin care is safe and feasible for preterm babies and their parents in the NICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.